• Publications
  • Influence
Sixth INTERMACS annual report: a 10,000-patient database.
The sixth annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 8 years of patient enrollment. The analysis is based on data fromExpand
  • 703
  • 57
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The currentExpand
  • 633
  • 46
Seventh INTERMACS annual report: 15,000 patients and counting.
The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000Expand
  • 984
  • 40
The Fourth INTERMACS Annual Report: 4,000 implants and counting.
The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more thanExpand
  • 369
  • 28
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
Background— Contemporary ventricular assist device therapy results in a high rate of successful heart transplantation but is associated with bleeding, infections, and other complications. FurtherExpand
  • 488
  • 22
Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.
BACKGROUND The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database now includes >20,000 patients from >180 hospitals. METHODS The eighth annual report ofExpand
  • 577
  • 21
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
BACKGROUND Pump thrombosis remains an uncommon but potentially catastrophic complication of durable continuous-flow left ventricular assist devices (LVAD). A perceived increase in the incidence ofExpand
  • 332
  • 19
Replacement of the aortic root in patients with Marfan's syndrome.
BACKGROUND Replacement of the aortic root with a prosthetic graft and valve in patients with Marfan's syndrome may prevent premature death from rupture of an aneurysm or aortic dissection. WeExpand
  • 580
  • 16
Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.
The Interagency Registry For Mechanical Circulatory Support (INTERMACS)1 an NHLBI-sponsored collaboration between the National Heart, Lung, and Blood Institute (NHLBI), the Food and DrugExpand
  • 361
  • 15
  • PDF
INTERMACS profiles of advanced heart failure: the current picture.
BACKGROUND The current classification of patients with New York Heart Association Class IV symptoms does not offer adequate description to allow optimal selection of patients for the current optionsExpand
  • 493
  • 13